Bioventus (BVS) Non-Current Debt (2020 - 2026)

Bioventus (BVS) has reported Non-Current Debt for 7 consecutive years, with $229.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt fell 22.89% year-over-year to $229.7 million; the trailing twelve-month figure through Jun 2026 stood at $229.7 million (down 22.89% YoY), and the FY2025 full-year result was $279.0 million, down 9.52% from the prior year.
• Non-Current Debt declined to $229.7 million in Q2 2026 per BVS's latest filing, from $253.3 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $404.3 million in Q2 2023 and bottomed at $229.7 million in Q2 2026.
• Historically, Non-Current Debt has averaged $335.1 million across 5 years, with a median of $346.5 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Non-Current Debt surged 142.0% in 2022, then slipped 22.89% in 2026.
• Over 5 years, Non-Current Debt stood at $385.0 million in 2022, then fell by 4.68% to $367.0 million in 2023, then dropped by 16.0% to $308.3 million in 2024, then dropped by 9.52% to $279.0 million in 2025, then slipped by 17.66% to $229.7 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $229.7 million, $253.3 million, and $279.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.